Statins differ in their ability to block NF-kB activation in human blood monocytes

2003130 citationsJournal Article

Authors

Anne Hilgendorff · University of Giessen

Heidrun Muth

Abstract

The finding that statins differ in their potency in interfering with the activation of NF-kappaB signaling in human monocytes further supports the hypothesis that some statins inhibit the inflammatory response more than others.

Topics & Keywords

NF-κB Signaling Pathways Lipoproteins and Cardiovascular Health interferon and immune responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Clinical Pharmacology and Therapeutics

Volume 41, Issue 09, pp. 397-401

DOI: 10.5414/cpp41397

Field-Weighted Citation Impact: 4.19